Tuesday 07 May 2024
Internal Reference Number: FOI_7363
Date Request Received: 09/08/2023 00:00:00
Date Request Replied To: 12/09/2023 00:00:00
This response was sent via: By Email
Request Summary: Real-world usage of Ruxolitinib
Request Category: Private Individuals
| Question Number 1: Real-world usage of Ruxolitinib. Could you please tell me how many patients your Trust has treated in the past 6 months (for any disease) with the following: Ruxolitinib - any strength Ruxolitinib 5mg tablets or Ruxolitinib 10mg tablets In case you are able to link Ruxolitinib usage to disease, could you also provide the number of patients treated in the last 6 months for myelofibrosis ONLY with Ruxolitinib - any strength Ruxolitinib 5mg tablets or Ruxolitinib 10mg tablets | |
| Answer To Question 1: Could you please tell me how many patients your Trust has treated in the past 6 months (for any disease) with the following: Ruxolitinib - any strength 12 Ruxolitinib 5mg tablets or Ruxolitinib 10mg tablets <5 In case you are able to link Ruxolitinib usage to disease, could you also provide the number of patients treated in the last 6 months for myelofibrosis ONLY with Ruxolitinib - any strength 11 Ruxolitinib 5mg tablets or Ruxolitinib 10mg tablets <5 | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
